VOV.VN - The initial six volunteers participating in human trials of Covivac, the second locally-produced COVID-19 vaccine, remain in stable condition after receiving a dose of the experimental vaccine on March 15.
VOV.VN - The Hanoi Medical University is to start the initial phase of clinical trials on the second domestically-produced COVID-19 vaccine known as Covivac, developed by the Institute of Vaccines and Medical Biologicals (IVAC) on March 15.
VOV.VN - The Institute of Vaccines and Medical Biologicals (IVAC) unveiled on the morning of March 5 that they have begun the process of receiving registrations from volunteers to participate in the initial phase of clinical trials for the second domestically-produced COVID-19 vaccine known as Covivac.
VOV.VN - Covivac, a COVID-19 vaccine developed by the Institute of Vaccines and Medical Biology (Ivac), will be tested in healthy volunteers in Vietnam on March 3, Ivac has announced.
VOV.VN - The initial batch of 204,000 doses of AstraZeneca’s novel coronavirus (COVID-19) vaccine are set to arrive in Vietnam over the coming days, with the focus now turning to which group of people will be prioritised to receive the first doses.
Vietnam scored 62.4 points compared to 53.8 in Malaysia, 52.7 in Singapore, 52 in Thailand, and 49.6 in Indonesia.
VOV.VN - A launching ceremony to mark the start of the clinical trial research scheme for the locally-produced novel coronavirus (COVID-19) vaccine, named COVIVAC, took place on January 21 at the Hanoi Medical University.
VOV.VN - The Ministry of Health has permitted the Institute of Vaccines and Medical Biologicals (IVAC) to carry out clinical human trials of its produced vaccine COVIVAC, starting in a couple of weeks.
VOV.VN - At present Vietnam has successfully produced two novel coronavirus (COVID-19) vaccines, namely Nanocovax and Covivac.
VOV.VN -The Ministry of Health has granted permission to the Nha Trang-based Institute of Vaccines and Biological Medical (IVAC) to carry out human clinical tests for Covivac, a locally-produced novel coronavirus (COVID-19) vaccine, on volunteers in January, two months ahead of schedule.